Search results
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 2 days agoRegeneron and Sanofi could soon be adding another indication to its blockbuster immunology drug...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 21 hours agoThe senior author Rachael Bashford-Rogers is a co-founder of Alchemab and the paper was a collaboration between the Cancer Dynamics Group at The Institute of Cancer...
Earnings call: Nektar Therapeutics optimistic on REZPEG and pipeline progress By Investing.com
Investing.com· 5 days agoNektar Therapeutics (NASDAQ:NKTR) reported a productive first quarter of 2024, focusing on their ...
Mutations protected mice from B-cell cancers | Newswise
Newswise· 24 hours ago“We used a purely genetic method to find a drug target, and that target turns out to be sensational...
Systemic antibiotics in first year of life tied to higher atopic dermatitis risk
Medical Xpress· 6 days agoCourtney Hoskinson, from the University of British Columbia in Vancouver, Canada, and colleagues...
Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
Benzinga· 5 days agoTakeda said it will incur restructuring costs of about 140 billion yen in fiscal year 2024 as part...
Story from Argenx: “Untold Stories” Podcast Shares Powerful Tales of Strength and Perseverance Amid...
USA Today· 12 hours agoPeople living with severe autoimmune disorders often feel unseen and unheard, either because others...
Nektar Therapeutics (NKTR) First Quarter 2024 Earnings Overview
Guru Focus· 4 days agoThe biopharmaceutical company, known for its innovative approach in immunology and oncology, reported a net loss of $36.8 million, or $0.19 per share, aligning with analyst ...
Iron fuels immune cells – and it could make asthma worse
The Raw Story· 13 hours agoYou might also know that it’s an essential trace element that is a major component of hemoglobin, a...
7 Surprising Asthma Triggers to Know About
GQ via Yahoo News· 5 days ago“Viral infections, allergen exposure, and exposure to irritants and poor air quality are the most common triggers of asthma exacerbation,” says Jeffrey...
